MA52222A - COMPOSITION, IN THE FORM OF A SOFT CAPSULE, CONSISTING OF A COMBINATION OF OLIVE EXTRACTS, RED RICE YEAST AND CROCUS SATIVUS AND ASSOCIATED PREPARATION PROCESS - Google Patents
COMPOSITION, IN THE FORM OF A SOFT CAPSULE, CONSISTING OF A COMBINATION OF OLIVE EXTRACTS, RED RICE YEAST AND CROCUS SATIVUS AND ASSOCIATED PREPARATION PROCESSInfo
- Publication number
- MA52222A MA52222A MA052222A MA52222A MA52222A MA 52222 A MA52222 A MA 52222A MA 052222 A MA052222 A MA 052222A MA 52222 A MA52222 A MA 52222A MA 52222 A MA52222 A MA 52222A
- Authority
- MA
- Morocco
- Prior art keywords
- composition
- combination
- preparation process
- soft capsule
- red rice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18167383 | 2018-04-13 | ||
PCT/EP2019/059117 WO2019197481A1 (en) | 2018-04-13 | 2019-04-10 | Composition, in the form of a soft capsule, comprising a combination of extracts from olive fruit, red yeast rice and crocus sativus l. and method of preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
MA52222A true MA52222A (en) | 2021-02-17 |
MA52222B1 MA52222B1 (en) | 2022-05-31 |
Family
ID=62002039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA52222A MA52222B1 (en) | 2018-04-13 | 2019-04-10 | Composition, in the form of a soft capsule, comprising a combination of extracts of olive, red yeast rice and crocus sativus l. And its method of preparation |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR114767A1 (en) |
MA (1) | MA52222B1 (en) |
TW (1) | TW201943426A (en) |
-
2019
- 2019-04-09 TW TW108112285A patent/TW201943426A/en unknown
- 2019-04-10 MA MA52222A patent/MA52222B1/en unknown
- 2019-04-10 AR ARP190100949A patent/AR114767A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA52222B1 (en) | 2022-05-31 |
AR114767A1 (en) | 2020-10-14 |
TW201943426A (en) | 2019-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016170348A3 (en) | Sarna compositions and methods of use | |
MX2019012081A (en) | Human fibroblast growth factor 21 (hfgf21) fusion protein, preparation method therefor, and use thereof. | |
MY196200A (en) | Human Immunodeficiency Virus Neutralizing Antibodies | |
WO2018115097A9 (en) | Ophthalmic composition for treatment of dry eye disease | |
WO2019125011A3 (en) | Transdermal delivery complex using metal-organic framework and nanocellulose | |
WO2019142149A3 (en) | Methods of treating cancers with antagonistic anti-pd-1 antibodies | |
WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
TW201613936A (en) | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | |
SG10201803331PA (en) | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases | |
WO2021021837A3 (en) | Anti-pvrig antibodies formulations and uses thereof | |
WO2018005519A3 (en) | Cancer treatment combinations | |
MX2017007178A (en) | Stable liquid vaccinia virus formulations. | |
MX2022002946A (en) | Cdk inhibitors and their use as pharmaceuticals. | |
EP2724711A3 (en) | Hair care product with selected amino acids and/or selected oligopeptides and a selected cationic keratin hydrolysate | |
EP3825308A4 (en) | Compound, composition, and use thereof in preparation of drug | |
BR112018011310A2 (en) | A mutant of human papillomavirus type 58 L1 protein | |
NO20073813L (en) | Cladribine regimen for the treatment of multiple sclerosis | |
WO2016020880A3 (en) | Angiopoietin-like 4 antibodies and methods of use | |
MX2022006940A (en) | Pharmaceutical compositions comprising cabotegravir. | |
EP3636275A4 (en) | Pharmaceutical composition for preventing or treating neovascular disease, containing collagen type i and pigment epithelium derived factor peptide as active ingredients | |
WO2022184854A3 (en) | Formulations of ace2 fc fusion proteins | |
MA52222A (en) | COMPOSITION, IN THE FORM OF A SOFT CAPSULE, CONSISTING OF A COMBINATION OF OLIVE EXTRACTS, RED RICE YEAST AND CROCUS SATIVUS AND ASSOCIATED PREPARATION PROCESS | |
WO2009084036A3 (en) | Composition for treatment of viral infections | |
EA202091308A1 (en) | MODIFIED BRUCELLA VACCINE STRAIN FOR THE TREATMENT OF BRUCELLOSIS | |
WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib |